Printer Friendly

GENETIC LABORATORIES WOUND CARE REPORTS PROFITS FOR THE THIRD QUARTER OF FISCAL 1992

 GENETIC LABORATORIES WOUND CARE REPORTS PROFITS
 FOR THE THIRD QUARTER OF FISCAL 1992
 ST. PAUL, Minn., April 9 /PRNewswire/ -- Genetic Laboratories Wound Care, Inc. (GLWC) has announced revenues for the three months ended Feb. 28, 1992 were $438,160 compared to revenues of $462,903 for the three months ended Feb. 28, 1991. Net income was $11,708 for the three months ended Feb. 28, 1992, compared to $13,212 for the three months ended Feb. 28, 1991.
 Revenues for the nine months ended Feb. 28, 1992 were $1,412,807 compared to revenues of $1,444,171 for the nine months ended Feb. 28, 1991. Net income was $68,632 for the nine months ended Feb. 28, 1992, compared to $86,581 for the nine months ended Feb. 28, 1991.
 GLWC is engaged in the business of manufacturing and marketing wound care products. GLWC is currently traded on the local over-the-counter market. GLWC has a fiscal year ended May 31.
 GENETIC LABORATORIES WOUND CARE
 SUMMARY OF OPERATIONS
 (Unaudited)
 Three Months Ended
 2/28/92 2/28/91
 Net revenues $438,160 $462,903
 Percent change -5.3 --
 Expenses 426,452 449,691
 Net income $11,708 $13,212
 Per common share income $.01 $.01
 Nine Months Ended
 2/28/92 2/28/91
 Net revenues $1,412,807 $1,444,171
 Expenses 1,344,175 1,357,590
 Net income $68,632 $86,581
 Per common share income $.03 $.04
 -0- 4/9/92
 /CONTACT: Jim Thompson of Genetic Laboratories Wound Care, 612-633-0805/ CO: Genetic Laboratories Wound Care, Inc. ST: Minnesota IN: MTC SU: ERN


AL -- MN004 -- 6616 04/09/92 09:17 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 9, 1992
Words:275
Previous Article:SEARS REPORTS MARCH REVENUES
Next Article:MARCH DOMESTIC COMPARABLE STORE SALES DECLINED 9.9 PERCENT AT WOOLWORTH


Related Articles
GENETIC LABORATORIES WOUND CARE REPORTS PROFITS FOR THE SECOND QUARTER OF FISCAL 1992
GENETIC LABORATORIES WOUND CARE, INC. REPORTS INCREASED REVENUES AND PROFITS FOR 12 MONTHS ENDED MAY 31, 1992
GENETIC LABORATORIES WOUND CARE REPORTS INCREASED REVENUES FOR FIRST QUARTER OF FISCAL 1993
VARLEN MAINTAINS RECOVERY; EARNINGS UP 92 PERCENT FOR THIRD QUARTER; TRANSPORTATION SEGMENT CONTINUES TO PACE GAINS
GENETIC LABORATORIES WOUND CARE REPORTS PROFITS FOR THE SECOND QUARTER OF FISCAL 1993
GENETIC LABORATORIES WOUND CARE REPORTS PROFITS FOR THE THIRD QUARTER OF FISCAL 1993
GELMAN SCIENCES INC. REPORTS RECORD EARNINGS AND SALES IN THE THIRD QUARTER
GENETIC LABORATORIES HAS ACCEPTED THE RESIGNATION OF HOLMAN FROM THE BOARD OF DIRECTORS
GENETIC LABORATORIES WOUND CARE, INC. REPORTS RESULTS FOR 12 MONTHS ENDED MAY 31, 1993
GENETIC LABORATORIES WOUND CARE REPORTS INCREASED PROFITS FOR THE FIRST QUARTER OF FISCAL 1994

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters